Your browser doesn't support javascript.
loading
The ß-arrestin1/endothelin axis bolsters ovarian fibroblast-dependent invadosome activity and cancer cell metastatic potential.
Del Rio, Danila; Masi, Ilenia; Caprara, Valentina; Ottavi, Flavia; Albertini Petroni, Gabriele; Salvati, Erica; Trisciuoglio, Daniela; Giannitelli, Sara Maria; Bagnato, Anna; Mauri, Emanuele; Spadaro, Francesca; Rosanò, Laura.
Afiliación
  • Del Rio D; Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, 00185, Italy.
  • Masi I; Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, 00185, Italy.
  • Caprara V; Unit of Preclinical Models and New Therapeutic Agents, IRCCS-Regina Elena National Cancer Institute, Rome, 00144, Italy.
  • Ottavi F; Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, 00185, Italy.
  • Albertini Petroni G; Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, 00185, Italy.
  • Salvati E; Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, 00185, Italy.
  • Trisciuoglio D; Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, 00185, Italy.
  • Giannitelli SM; Department of Science and Technology for Sustainable Development and One Health, University Campus Bio-Medico di Roma, Rome, 00128, Italy.
  • Bagnato A; Unit of Preclinical Models and New Therapeutic Agents, IRCCS-Regina Elena National Cancer Institute, Rome, 00144, Italy.
  • Mauri E; Department of Chemistry Materials and Chemical Engineering, University Politecnico di Milano, 20133, Milano, Italy.
  • Spadaro F; Confocal Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, Rome, 00161, Italy.
  • Rosanò L; Institute of Molecular Biology and Pathology (IBPM), National Research Council (CNR), Rome, 00185, Italy. laura.rosano@cnr.it.
Cell Death Dis ; 15(5): 358, 2024 May 22.
Article en En | MEDLINE | ID: mdl-38777849
ABSTRACT
Recruitment of fibroblasts to tumors and their activation into cancer-associated fibroblasts (CAFs) is a strategy used by tumor cells to direct extracellular matrix (ECM) remodeling, invasion, and metastasis, highlighting the need to investigate the molecular mechanisms driving CAF function. Endothelin-1 (ET-1) regulates the communication between cancer and stroma and facilitates the progression of serous ovarian cancer (SOC). By binding to Endothelin A (ETA) and B (ETB) receptors, ET-1 enables the recruitment of ß-arrestin1 (ß-arr1) and the formation of signaling complexes that coordinate tumor progression. However, how ET-1 receptors might "educate" human ovarian fibroblasts (HOFs) to produce altered ECM and promote metastasis remains to be elucidated. This study identifies ET-1 as a pivotal factor in the activation of CAFs capable of proteolytic ECM remodeling and the generation of heterotypic spheroids containing cancer cells with a propensity to metastasize. An autocrine/paracrine ET-1/ETA/BR/ß-arr1 loop enhances HOF proliferation, upregulates CAF marker expression, secretes pro-inflammatory cytokines, and increases collagen contractility, and cell motility. Furthermore, ET-1 facilitates ECM remodeling by promoting the lytic activity of invadosome and activation of integrin ß1. In addition, ET-1 signaling supports the formation of heterotypic HOF/SOC spheroids with enhanced ability to migrate through the mesothelial monolayer, and invade, representing metastatic units. The blockade of ETA/BR or ß-arr1 silencing prevents CAF activation, invadosome function, mesothelial clearance, and the invasive ability of heterotypic spheroids. In vivo, therapeutic inhibition of ETA/BR using bosentan (BOS) significantly reduces the metastatic potential of combined HOFs/SOC cells, associated with enhanced apoptotic effects on tumor cells and stromal components. These findings support a model in which ET-1/ß-arr1 reinforces tumor/stroma interaction through CAF activation and fosters the survival and metastatic properties of SOC cells, which could be counteracted by ETA/BR antagonists.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Podosomas / Fibroblastos Asociados al Cáncer / Beta-Arrestina 1 Límite: Animals / Female / Humans Idioma: En Revista: Cell Death Dis Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Podosomas / Fibroblastos Asociados al Cáncer / Beta-Arrestina 1 Límite: Animals / Female / Humans Idioma: En Revista: Cell Death Dis Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido